[HTML][HTML] Considerations for treatment duration in responders to immune checkpoint inhibitors

TU Marron, AE Ryan, SM Reddy… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients,
however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to …

[PDF][PDF] Considerations for treatment duration in responders to immune checkpoint inhibitors

TU Marron, AE Ryan, SM Reddy, S Kaczanowska… - academia.edu
Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients,
however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to …

Considerations for treatment duration in responders to immune checkpoint inhibitors

TU Marron, AE Ryan, SM Reddy… - Journal for …, 2021 - utsouthwestern.elsevierpure.com
Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients,
however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to …

Considerations for treatment duration in responders to immune checkpoint inhibitors

TU Marron, AE Ryan, SM Reddy… - Journal for …, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients,
however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to …

Considerations for treatment duration in responders to immune checkpoint inhibitors

TU Marron, AE Ryan, SM Reddy… - Journal for …, 2021 - search.proquest.com
Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients,
however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to …

[HTML][HTML] Considerations for treatment duration in responders to immune checkpoint inhibitors

TU Marron, AE Ryan, SM Reddy… - … for ImmunoTherapy of …, 2021 - jitc.bmj.com
Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients,
however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to …

Considerations for treatment duration in responders to immune checkpoint inhibitors.

TU Marron, AE Ryan, SM Reddy… - … for Immunotherapy of …, 2021 - europepmc.org
Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients,
however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to …

Considerations for treatment duration in responders to immune checkpoint inhibitors.

TU Marron, AE Ryan, SM Reddy… - … for Immunotherapy of …, 2021 - europepmc.org
Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients,
however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to …